Moderna

American biotechnology company

MRNA Nasdaq ISIN US60770K1079 SEC CIK 1682852 LEI 549300EI6OKH5K5Q2G38
Follow Moderna Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.3B +29.2% vs same quarter last year
Net income $162M +181% vs same quarter last year
EPS, diluted $0.38 +174.5% vs same quarter last year
Operating cash flow −$1.6B −84.1% vs same quarter last year
Revenue by quarter
$966M
$108M
$142M
$1B
$678M
$389M
$145M
$1.3B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income11 fiscal years
  • Revenue
  • Net income
−$10B$0$10B$20BFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$1.9B−$2.8B
FY24$3.2B−$3.6B
FY23$6.8B−$4.7B
FY22$19.3B$8.4B
FY21$18.5B$12.2B
FY20$803M−$747M
FY19$60.2M−$514M
FY18$135.1M−$384.7M
FY17$205.8M−$255.9M
FY16$108.4M−$216.2M
FY15--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1000%−500%0%500%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2555.3%−158.1%−145.2%
FY2454.8%−121.9%−110%
FY2331.5%−61.9%−68.8%
FY2271.9%48.9%43.4%
FY2185.8%72%66.1%
FY2099%−95%−93%
FY19100%−906.8%−853.7%
FY18100%−306%−284.8%
FY17-−130.9%−124.3%
FY16-−206.4%−199.5%
FY15---
Free cash flowOperating cash flow minus capital expenditure
−$5B$0$5B$10B$15BFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$2.1B
FY24−$4.1B
FY23−$3.8B
FY22$4.6B
FY21$13.3B
FY20$2B
FY19−$491M
FY18−$436.6M
FY17−$389.9M
FY16$33.6M
FY15-
Returned to shareholdersDividends paid and shares bought back
$0$1B$2B$3B$4BFY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$2M
FY24$0
FY23$1.2B
FY22$3.3B
FY21$857M
FY20$0
FY19$0
FY18-
FY17-
FY16-
FY15-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Moderna
  • Healthcare median
−1000%−750%−500%−250%0%250%FY15FY17FY19FY21FY23FY25
Show the numbers
YearModernaHealthcare median
FY25−145.2%−30.6%
FY24−110%−47%
FY23−68.8%−58%
FY2243.4%−80.4%
FY2166.1%−71.9%
FY20−93%−62.2%
FY19−853.7%−46.3%
FY18−284.8%−49.6%
FY17−124.3%−45.9%
FY16−199.5%−36%
FY15-−38.4%